Results 221 to 230 of about 136,281 (235)

An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study

Lancet, The, 2023
E Guttman-Yassky, Kenji Kabashima, Masutaka Furue   +2 more
exaly  

Atopic Dermatitis

Southern Medical Journal, 1971
openaire   +2 more sources

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Lancet, The, 2020
Rd Sinclair, Andreas Wollenberg, Michael J Cork   +2 more
exaly  

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

Nature Reviews Drug Discovery, 2021
Thomas Bieber
exaly  

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Lancet, The, 2017
Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham   +2 more
exaly  

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Lancet, The, 2016
Thomas Bieber, Andrew Blauvelt, Margitta Worm   +2 more
exaly  

Atopic Dermatitis

Pediatric Clinics of North America, 1983
openaire   +2 more sources

Atopic dermatitis therapy breakthrough on the horizon?

Nature Reviews Drug Discovery, 2014
Megan Cully
exaly  

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial

Lancet, The, 2020
Håvard Ove Skjerven, Eva Maria Rehbinder, Riyas Vettukattil   +2 more
exaly  

Atopic Dermatitis

Archives of Dermatology, 1979
openaire   +2 more sources